In an obese patient who is currently breastfeeding and has breast cancer, is it safe to use glucagon‑like peptide‑1 (GLP‑1) receptor agonists for weight loss?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board

Educational purpose only • Exercise caution as content is pending human review

Article Review Status

Submitted

Under Review

Approved

Last updated: February 14, 2026 • View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Related Questions

Are GLP-1 (Glucagon-like peptide-1) receptor agonists linked to an increased risk of breast cancer?

Are there any peptides other than Glucagon-like peptide-1 (GLP-1) that have health benefits supported by data?

What is the best Glucagon-like peptide-1 (GLP-1) receptor agonist for treating severe fatty liver and obesity?

Can a patient with unstable hypothyroidism and hypercholesterolemia, taking pravastatin and ezetimibe, start a GLP-1 (Glucagon-Like Peptide-1) receptor agonist for weight loss?

In a woman of reproductive age with class III obesity (BMI 41) attempting conception, what is the most appropriate initial management: GLP‑1 receptor agonist injection, bariatric surgery, or lifestyle modification with a structured caloric‑deficit plan?

For an otherwise healthy adult with uncomplicated community‑acquired pneumonia, should I prescribe doxycycline or moxifloxacin?

What is a safe, medically supervised tapering protocol for a patient who is taking a short‑acting benzodiazepine (e.g., alprazolam or lorazepam) as prescribed and also using cocaine, and wishes to discontinue both substances?

What is the Family APGAR and how is it used to assess family functioning in clinical practice?

In an otherwise healthy adult with community‑acquired pneumonia treated initially with moxifloxacin who then developed a viral upper‑respiratory infection and still has unresolved interstitial infiltrates/edema, can I discontinue moxifloxacin and start doxycycline?

What is a basic metabolic panel (BMP) and what components does it include?

Are GLP‑1 receptor agonists (exenatide, liraglutide, semaglutide) associated with an increased risk of breast cancer, and can they be safely used in a diabetic woman who has personal or family history of breast cancer?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.